DARZALEX ® (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast

DARZALEX & reg; (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast
Source: Johnson and Johnson Podcasts - Category: Pharmaceuticals Source Type: podcasts